Interaction between cytochrome P450 gene polymorphisms and serum organochlorine TEQ levels in the risk of endometriosis

Molecular Human Reproduction

Volumn 13, Issue 6, 2007, Pages 399-404

  Tsuchiya, Masaki ^a   Tsukino, Hiromasa ^a   Iwasaki, Motoki ^a   Sasaki, Hiroshi ^b   Tanaka, Tadao ^b   Katoh, Takahiko ^c   Patterson Jr , Donald G ^d   Turner, Wayman ^d   Needham, Larry ^d   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

CYP1A1; CYP1B1; Endometriosis; Gene environment interaction; Organochlorine

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DIOXIN; ISOLEUCINE; ORGANOCHLORINE DERIVATIVE; POLYCHLORINATED BIPHENYL; VALINE;

ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; ENVIRONMENTAL EXPOSURE; FEMALE; FEMALE INFERTILITY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; JAPANESE; LAPAROSCOPY; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; DIOXINS; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; POLYCHLORINATED BIPHENYLS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34447523957     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam018     Document Type: Article

References (34)

1. American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985;43 351-352.
2. Brennan P. Gene-environment interaction and aetiology of cancer: What does it mean and how can we measure it? Carcinogenesis 2002;23 381-387.
3. Eskenazi B, Mocarelli P, Warner M et al. Serum dioxin concentrations and endometriosis: A cohort study in Seveso, Italy. Environ Health Perspect 2002;110:629-634.
4. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1988;40:243-288.
5. Gottardis MM, Robinson SP, Satyaswaroop PG et al. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 1988;48:812-815.
6. Heilier JF, Nackers F, Verougstraete V et al. Increased dioxin-like compounds in the serum of women with peritoneal endometriosis and deep endometriotic (adenomyotic) nodules. Fertil Steril 2005;84:305-312.
7. Huang CS, Shen CY, Chang KJ et al. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer 1999;80:1838-1843.
8. Kennedy S. The genetics of endometriosis. J Reprod Med 1998;43 263-268.
9. Laden F, Ishibe N, Hankinson SE et al. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 2002;11:1560-1565.
10. Landi MT, Bergen AW, Baccarelli A et al. CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from Seveso, Italy. Toxicology 2005;207:191-202.
11. Lebel G, Dodin S, Ayotte P et al. Organochlorine exposure and the risk of endometriosis. Fertil Steril 1998;69:221-228.
12. Li Y, Millikan RC, Bell DA et al. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: A population-based case-control study. Breast Cancer Res 2005;7 R12-R18.
13. Louis GM, Weiner JM, Whitcomb BW et al. Environmental PCB exposure and risk of endometriosis. Hum Reprod 2005;20:279-285.
14. Marchino GL, Gennarelli G, Enria R et al. Diagnosis of pelvic endometriosis with use of macroscopic versus histologic findings. Fertil Steril 2005;84:12-15.
15. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 1993;57:237-257.
16. Mayani A, Barel S, Soback S et al. Dioxin concentrations in women with endometriosis. Hum Reprod 1997;12:373-375.
17. Missmer SA, Hankinson SE, Spiegelman D et al. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004a;160:784-796.
18. Missmer SA, Hankinson SE, Spiegelman D et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol 2004b;104:965-974.
19. Moysich KB, Shields PG, Freudenheim JL et al. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:41-44.
20. Ohtake F, Takeyama K, Matsumoto T et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003;423:545-550.
21. Pauwels A, Schepens PJ, D'Hooghe T et al. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: A case-control study of infertile women. Hum Reprod 2001;16 2050-2055.
22. Rawson JM. Prevalence of endometriosis in asymptomatic women. J Reprod Med 1991;36:513-515.
23. Signorello LB, Harlow BL, Cramer DW et al. Epidemiologic determinants of endometriosis: A hospital-based case-control study. Ann Epidemiol 1997;7:267-271.
24. Solus JF, Arietta BJ, Harris JR et al. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics 2004;5:895-931.
25. Tang YM, Green BL, Chen GF et al. Human CYP1B1 Leu432Val gene polymorphism: Ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics 2000;10:761-766.
26. Toppari J, Larsen JC, Christiansen P et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996;104: 741-803.
27. Treloar SA, O'Connor DT, O'Connor VM et al. Genetic influences on endometriosis in an Australian twin sample. Fertil Steril 1999; 71: 701-710.
28. Tsukino H, Hanaoka T, Sasaki H et al. Associations between serum levels of selected organochlorine compounds and endometriosis in infertile Japanese women. Environ Res 2005;99:118-125.
29. Van den Berg M, Birnbaum L, Bosveld AT et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 1998;106:775-792.
30. Whysner J, Williams GM. 2,3,7,8-Tetrachlorodibenzo-p-dioxin mechanistic data and risk assessment: Gene regulation, cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 1996;71: 193-223.
31. Yang JZ, Agarwal SK, Foster WG. Subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey. Toxicol Sci 2000;56 374-381.
32. Yang Q, Khoury MJ, Flanders WD. Sample size requirements in case-only designs to detect gene-environment interaction. Am J Epidemiol 1997;146:713-720.
33. Zhang Y, Wise JP, Holford TR et al. Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol 2004;160:1177-1183.
34. Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 2002;17:1415-1423.